The proteome of parental (PAR) and engineered MDA‐MB‐231 cells expressing low or high KLK6 levels was analyzed by HPLC‐MS/MS to identify putative molecular pathways underlying the observed, tumor suppression or promotion, respectively. The gene discussed is KLK6; the disease is neoplasm.